Jubo Liu

Jubo Liu is the current CEO of Evive Biotech. Prior to this, they worked at BIOTON S.A., Novotek Therapeutics Inc, and Immtech. At Immtech, Jubo served as the chief representative and was responsible for setting up a China representative office and recruiting a team. Jubo also oversaw a Phase III global trial, working closely with a contracted clinical trial team and local contract research organizations. In addition, Jubo established a strategic alliance with Beijing Pharmaceutical Group Co. Ltd. (BPGC) in exploring the development of Immtech’s patent compounds as potential drug candidates in China. Finally, they set up collaboration between Immtech and various research institutions, including Beijing Capital Medical University.

After Jubo Liu completes their undergraduate degree, they plan to attend graduate school to earn their Doctor of Philosophy (Ph.D.) in Pharmaceuticals at the University of Toronto.

Some individuals on their team include Simon Li - EVP, Chief Medical Officer, Juhong Liu - Chief Science Officer, and Roujian Zhang - Chief Quality Officer.